Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Dexamethasone Palmitate for Postoperative Pain: A New Lipid-Formulated Option

Official title: Effect of Intravenous Dexamethasone Palmitate on Postoperative Pain Prevention

Run by Beijing Tiantan Hospital · NCT07341854 · Data updated 2026-11-12

This study tests whether preoperative intravenous dexamethasone palmitate helps reduce moderate-to-severe postoperative pain better than conventional dexamethasone.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment446 (estimated)
SponsorBeijing Tiantan Hospital
Academic / other
Locations1 site (Beijing, China)
StatusRecruiting
StartedApril 6, 2026
Main results expectedJune 30, 2027
Study endsDecember 30, 2027
Registry record updatedAugust 19, 2026
Trial IDNCT07341854 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 undergoing various general anesthesia surgeries who can consent and understand study procedures (ASA I–III).

Probably not a fit

Those with recent systemic glucocorticoid use, true dexamethasone allergy, or significant comorbidities may derive less or no benefit and could be excluded from analysis.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional trial investigates a lipophilic prodrug, dexamethasone palmitate, given before surgery to target inflammatory sites and reduce pain after various procedures. It compares dexamethasone palmitate with standard dexamethasone to see if it lowers pain scores and opioid needs without increased side effects. The study includes adults 18–65 undergoing a range of general anesthesia surgeries, from minimally invasive to open procedures. Primary outcomes focus on postoperative pain intensity and analgesic consumption, with safety monitoring for corticosteroid-related adverse events. The trial is conducted at Beijing Tiantan Hospital and partner centers in Beijing, China.

Why it matters

Potential benefit: If successful, patients may experience better pain control with lower opioid use and fewer systemic side effects.

How similar studies have gone: Previous uses of perioperative dexamethasone show benefit, but targeted lipophilic prodrugs like dexamethasone palmitate are being explored for potential superior efficacy.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 18-65 years.
2. Scheduled for a range of surgeries under general anesthesia, including both minimally invasive procedures (such as video-assisted thoracoscopic surgery and laparoscopy) and open surgeries (such as thoracotomy, laparotomy, spinal surgery, total joint replacement, and mastectomy).
3. Capacity to comprehend the study procedures and assessment scales, and communicate effectively with research staff.

4)Classified as American Society of Anesthesiologists (ASA) physical status I, II, or III.

5\) Willingness to participate voluntarily and provide written informed consent.

Exclusion Criteria:

1. Known hypersensitivity to dexamethasone or its excipients.
2. Systemic glucocorticoid therapy within 3 months prior to enrolment.
3. History of severe cardiovascular disease, hepatic or renal failure, or systemic rheumatic disease (e.g., rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus).
4. Coexisting chronic pain at enrolment.
5. Uncontrolled diabetes mellitus or active systemic infection.
6. Use of any systemic or topical analgesics within 48 hours prior to surgery.
7. Significant cognitive impairment or severe psychiatric disorder.
8. Pregnancy or lactation.

Where it's running

  • Fang Luo
    Beijing, China, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.